Qiagen N.V.
QGEN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,690 | $10,408 | $8,768 | $9,898 |
| - Cash | $1,356 | $734 | $639 | $664 |
| + Debt | $2,127 | $1,444 | $1,408 | $1,416 |
| Enterprise Value | $10,461 | $11,118 | $9,537 | $10,650 |
| Revenue | $533 | $534 | $483 | $521 |
| % Growth | -0.2% | 10.4% | -7.2% | – |
| Gross Profit | $331 | $334 | $309 | $333 |
| % Margin | 62.2% | 62.7% | 63.8% | 63.9% |
| EBITDA | $277 | $184 | $171 | $183 |
| % Margin | 52.1% | 34.5% | 35.3% | 35% |
| Net Income | $130 | $96 | $91 | $88 |
| % Margin | 24.4% | 18% | 18.8% | 16.9% |
| EPS Diluted | 0.6 | 0.44 | 0.41 | 0.41 |
| % Growth | 36.4% | 7.3% | 0% | – |
| Operating Cash Flow | $165 | $161 | $140 | $192 |
| Capital Expenditures | -$46 | -$41 | -$44 | -$50 |
| Free Cash Flow | $119 | $121 | $96 | $142 |